Intended use and classification review
Define disease, users, inputs, outputs, environment and clinical role, with the rationale for classification, grade and route.
Medical & healthcare
The applicable route depends on diagnostic or therapeutic claims, users and the effect of outputs on clinical decisions. SaMD describes standalone medical device software, not a single certification product. Specify helps draft documentation from source code for your team to edit and manage. Optional expert review is separate; the relevant authority decides approval.
Source record updated:
Discuss your certification →Applicable Korean manufacturing, import and product regulatory procedures
Digital medical devices fall under Korea's Digital Medical Products Act, with relevant application of medical device or in-vitro diagnostic legislation where needed. As of 2026-10-24, distinguish the Act effective 2026-10-08 from amendments scheduled for 2027-03-16. Existing authorized products require transition and change review.
Korean certification schemes and international standards are different. A translated guide does not extend a Korean certificate to other countries. Confirm the target market, product classification and current requirements with the relevant body.
Define disease, users, inputs, outputs, environment and clinical role, with the rationale for classification, grade and route.
Connect requirements, architecture, versions, test plans, results and traceability to claimed functions.
Organize risk, usability, performance, clinical and security evidence around product requirements.
Define sites, outsourcing, QMS and GMP scope and post-release update controls.
Review medical purpose, device type, existing authorizations and exceptions; prepare unclear issues for authority consultation.
Build the route-specific evidence list and prepare software, security, performance, clinical and GMP work together.
Coordinate business and product procedures, respond to authority requests and plan labeling, reporting and updates.
Classification, clinical evidence needs, development maturity and corrections affect duration. Separate evidence preparation from authority processing time.
Online: KRW 144,000
Enforcement Rule Schedule 16 lists KRW 160,000 for in-person or postal applications. Product authorization, GMP, testing and consulting are separate.
Sources and references ↗Online: KRW 158,000 / 719,000 / 1,495,000
Respectively: no review; other review; review of clinical evaluation data, change management plans or professional-use software materials. Confirm certification and notification fees separately. These are application fees, not total project prices.
Sources and references ↗Document automation and management cost KRW 300,000 per month. Expert services and certification body testing or assessment fees are separate. Specify supports preparation; the relevant authority or certification body makes the final decision.
Pricing and certification costs →Expert review and consulting are optional, separately scoped services. Choose support for Medical Device Software Regulatory Approval based on your team's readiness and the evidence or assessment preparation you need.
No. Intended use and functions determine the category; review applicable exclusions for the specific software.
No. Software quality and organizational QMS certification do not automatically replace product-specific regulatory procedures.
Assess effects on intended use, algorithms, performance, safety and quality systems, including product and GMP change requirements.